Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-01

FDA Approved: QUINAPRIL — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for quinapril filed by Solco Healthcare US, LLC under ANDA205823.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quinapril (quinapril)

Snippet

SUPPL AP for QUINAPRIL (QUINAPRIL)